Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell

Journal of Cell Biology

Volumn 141, Issue 6, 1998, Pages 1301-1310

  Abbondanza, Ciro ^a   Rossi, Valentina ^a   Roscigno, Annarita ^a   Gallo, Luigi ^a   Belsito, Angela ^a   Piluso, Giulio ^a   Medici, Nicola ^a   Nigro, Vincenzo ^a   Molinari, Anna Maria ^a   Moncharmont, Bruno ^a   Puca, Giovanni A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; LUNG RESISTANCE PROTEIN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; RECEPTOR ANTIBODY; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN TARGETING;

ANIMALS; BREAST NEOPLASMS; ESTRADIOL; ESTROGENS; FEMALE; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; PRECIPITIN TESTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; RIBONUCLEOPROTEINS; RNA; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EUKARYOTA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0032526408     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.141.6.1301     Document Type: Article

References (55)

1. Abbondanza, C., A. De Falco, V. Nigro, N. Medici, I. Armetta, A.M. Molinari, B. Moncharmont, and G.A. Puca. 1993. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor. Steroids. 58:4-12.
2. Ausubel, F.M., R. Breint, R.E. Kingston, D.D. Moore, J.G. Seidman, J.G. Smith, and K. Struhl. 1996. Current Protocols in Molecolar Biology. Vol. 3. Wiley & Sons Inc., New York.
3. Beato, M. 1989. Gene regulation by steroid hormones. Cell. 56:335-344.
4. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: many actors in search for a plot. Cell. 83:851-857.
5. r 90,000 (HSP 90) reveals a "DNA like" structure: potential site of interaction with steroid receptors. Biochem. Biophys. Res. Commun. 159:140-147.
6. Cavaillès, V., S. Dauvois, P.S. Danielian, and M.G. Parker. 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA. 91:10009-10013.
7. Cavaillès, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P.J. Kushner, and G.P. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14:3741-3751.
8. Chambraud, B., M. Berry, G. Redeuilh, P. Chambon, and E.-E. Baulieu. 1990. Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes. J. Biol. Chem. 265:20686-20691.
9. Chugani, D.C., L.H. Rome, and N.L. Kedersha. 1993. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci. 106: 23-29.
10. Dingam, J.D., R.M. Lebivitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
11. Guiochon-Mantel, A., P. Lescop, S. Christin-Maitre, H. Loosfelt, M. Perrot-Applanat, and E. Milgrom. 1991. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO (Eur. Mol. Biol. Organ.) J. 10:3851-3859.
12. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 264:1455-1458.
13. Ing, N.H., J.M. Beekman, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1992. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267:17617-17623.
14. Izquierdo, M.A., A.G. van der Zee, J.B. Vermorken, P. van der Valk, J.A. Belien, G. Giaccone, G.L. Scheffer, M.J. Flens, H.M. Pinedo, P. Kenemans, et al. 1995. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J. Natl. Cancer Inst. 87:1230-1237.
15. Izquierdo, M.A., R.H. Shoemaker, M.J. Flens, G.L. Scheffer, L. Wu, T.R. Prather, and R.J. Scheper. 1996. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer. 65:230-238.
16. Jacq, X., C. Brou, J. Lutz, I. Davidson, P. Chambon, and L. Tora. 1994. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell. 79:107-117.
17. Kaelin, W.G., D.C. Palas, J.A. De Capio, F.J. Kaye, and D.M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1 A-binding region of the retinoblastoma gene product. Cell. 64:521-532.
18. Kedersha, N.L., and L.H. Rome. 1986. Isolation and characterization of a novel ribonucleoprotein particle: Large structures contain a single species of small RNA. J. Cell Biol. 103:699-709.
19. Kedersha, N.L., M.-C. Miquel, D. Bittner, and L.H. Rome. 1990. Vaults II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J. Cell Biol. 110:895-901.
20. Kedersha, N.L., J.E. Heuser, D.C Chugani, and L.H. Rome. 1991. Vaults III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J. Cell Biol. 112:225-235.
21. Kickhoefer, V.A., R.P. Searles, N.L. Kedersha, M.E. Garber, D.L. Johnson, and L.H. Rome. 1993. Vault ribonucleoprotein particles from rat and bull-frog contain a related small RNA that is transcribed by RNA polymerase III. J. Biol. Chem. 268:7868-7873.
22. Kickhoefer, V.A., K.S. Rajavel, G.L. Sceffer, W.S. Dalton, R.J. Scheper, and L.H. Rome. 1998. Vaults are up-regulated in multidrug-resistant cancer cell lines. J. Biol. Chem. 273:8971-8974.
23. King, W.J., and G.L. Greene. 1984. Monoclonal antibodies localize oestrogen receptor in the nuclei of target celis. Nature. 307:745-747.
24. Kumar, V., S. Green, A. Staub, and P. Chambon. 1986. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO (Eur. Mol. Biol. Organ.) J. 5:2231-2236.
25. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
26. Landel, C.C., P.J. Kushner, and G.L. Greene. 1994. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol. Endocrinol. 8:1407-1419.
27. Le Douarin, B., C. Zechel, J.M. Garnier, Y. Lutz, L. Tora, P. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO (Eur. Mol. Biol. Organ.) J. 14:2020-2033.
28. List, A.F., C.S. Spier, T.M. Grogan, C. Johnson, D. Roe, J.P. Greer, S.N. Wolff, H.J. Broxterman, G.L. Scheffer, R.J. Scheper, and W.S. Dalton. 1996. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood. 87:2464-2469.
29. Macfarlane, D.E. 1989. Two dimensional benzyldimethyl-n-hexadecylammonium chloride → sodium dodecylsulfate preparative polyacrylamide gel electrophoresis: a high capacity high resolution technique for the purification of proteins from complex mixtures. Anal. Biochem. 176:457-463.
30. Mader, S., V. Kumar, H. de Verneuil, and P. Chambon. 1989. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature. 338:271-274.
31. Marchetti, E., P. Querzoli, B. Moncharmont, I. Parikh, A. Bagni, A. Marzola. G. Fabris, and I. Nenci. 1987. Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer: correlation with estrogen receptor assay by dextran-coated charcoal method. Cancer Res. 47:2508-2513.
32. Mayer, M.-E., H. Gronemeyer, B. Turcotte, M.-T. Bocquel, D. Tassel, and P. Chambon. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell. 57:433-442.
33. Medici, N., V. Nigro, C. Abbondanza, B. Moncharmont, A.M. Molinari, and G.A. Puca. 1991. In vitro binding of the purified hormone-binding subunit of the estrogen receptor to oligonucleotides containing natural or modified sequences of an estrogen responsive element. Mol. Endocrinol. 5:555-563.
34. Moncharmont, B., G. Ramp, C.C.J. De Goeij, and M. Sluyser. 1991. Comparison of the estrogen receptor in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors. Cancer Res. 51:3843-3848.
35. Nieg, E.A. 1997. Nucleocytoplasmic transport: signals, mechanism and regulation. Nature. 386:779-787.
36. Oñate, S.A., S.Y. Tsai, M.J. Tsar, and B.W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1354-1357.
37. Pantè, N., and U. Aebi. 1996. Toward the molecular dissection of protein import into nuclei. Curr. Opin. Cell Biol. 8:397-406.
38. Picard, D., V. Kumar, P. Chambon, and K.R. Yamamoto. 1990. Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors. Cell Regul. 1:291-299.
39. Pugh, B.F., and R. Tijan. 1991. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5:1935-1945.
40. Redeuihl, G.J., B. Moncharmont, C.M. Secco, and E.-E. Baulieu. 1987. Subunit composition of the molybdate-stabilized "8-9 S" nontransformed estradiol receptor purified from calf uterus. J. Biol. Chem. 262:6969-6975.
41. Reinberg, D., and R.G. Roeder. 1987. Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IiB and IIE. J. Biol. Chem. 262:3310-3321.
42. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467.
43. Scheffer, G.L., P.L. Wijngaard, M.J. Flens, M.A. Izquierdo, M.L. Slovak, H.M. Pinedo, C.J. Meijerm H.C. Clevers, and R.J. Scheper. 1995. The drug resistance-related protein LRP is the human major vault protein. Nat. Med. 1:578-582.
44. Spencer, T.E., G. Jenster, M.M. Burcin, C.D. Allis, J . Zhou, C.A. Mizzen, N.J. McKenna, S.A. Oñate, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389:194-198.
45. Tanese, N., B.F. Pugh, and R. Tijan. 1991. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev. 5:2212-2224.
46. Tora, L., A. Mullick, D. Metzger, M. Ponglikitmongkol, I. Park, and P. Chambon. 1989a. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO (Eur. Mol. Biol. Organ.) J. 8:1981-1986.
47. Torn, L., J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon. 1989b. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 54:481-487.
48. Towbin, H., D. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
49. Vasu, K.S., and L.H. Rome. 1995. Dictyostelium vaults: disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein. J. Biol. Chem. 279:16588-16594.
50. Voegel, J.J., M.J.S. Heine, C. Zechel, H. Gronemeyer, and P. Chambon. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO (Eur. Mol. Biol. Organ.) J. 15:3667-3675.
51. vom Baur, E., C. Zechel, D.M. Heery, M.J.S. Heine, J.M. Garnier, V. Vivat, B. Le Douarin, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO (Eur. Mol. Biol. Organ.) J. 15:110-124.
52. Wakeling, A.E., M. Dukes, and J. Bowler. 1991. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:3867-3873.
53. Yang, J. and D.B. De Franco. 1996. Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking. Mol. Endocrinol. 10:3-13.
54. Ylikomi, T., M.T. Bocquel, M. Berry, H. Gronemeyer, and P. Chambon. 1992. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO (Eur. Mol. Biol. Organ.) J. 11:3681-3694.
55. Ziemiecki, A., M.-G. Catelli, I. Joab, and B. Moncharmont. 1986. Association of the heat shock protein hsp90 with steroid hormone receptors and tyrosine kinase oncogene products. Biochem. Biophys. Res. Commun. 138:1298-1307.